癌症临床试验中的核心症状测量指标。 - Suppr

Suppr

超能文献

Core symptom measures in cancer clinical trials.

作者信息

Gotay Carolyn

机构信息

Affiliation of author: University of British Columbia, Vancouver, BC (CG).

出版信息

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju173. Print 2014 Jul.

DOI:10.1093/jnci/dju173

PMID:25006193

Abstract

摘要

相似文献

Core symptom measures in cancer clinical trials.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju173. Print 2014 Jul.

J Natl Cancer Inst. 2015 Feb 6;107(4). doi: 10.1093/jnci/dju506. Print 2015 Apr.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju127. Print 2014 Jul.

Patient-reported outcomes: clinical trials in ovarian cancer.

Int J Gynecol Cancer. 2011 May;21(4):782-7. doi: 10.1097/IGC.0b013e31821bb8be.

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer.

Cancer Chemother Pharmacol. 1999;44(2):143-51. doi: 10.1007/s002800050959.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju128. Print 2014 Jul.

[23rd Congress of the European Society for Medical Oncology, 6-10 November 1998, Athens, Greece].

Clin Ter. 1998 Nov-Dec;149(6):401-7.

Exercise and cancer: no pain, some gain?

J Clin Oncol. 2003 May 1;21(9):1651-2. doi: 10.1200/JCO.2003.12.066.

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.

Clin Cancer Res. 1998 Apr;4(4):835-46.

Gene therapy trials: a patient pathway.

Nurs Stand. 2002;17(3):39-42. doi: 10.7748/ns.17.3.39.s63.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Core symptom measures in cancer clinical trials.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju173. Print 2014 Jul.

J Natl Cancer Inst. 2015 Feb 6;107(4). doi: 10.1093/jnci/dju506. Print 2015 Apr.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju127. Print 2014 Jul.

Patient-reported outcomes: clinical trials in ovarian cancer.

Int J Gynecol Cancer. 2011 May;21(4):782-7. doi: 10.1097/IGC.0b013e31821bb8be.

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer.

Cancer Chemother Pharmacol. 1999;44(2):143-51. doi: 10.1007/s002800050959.

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju128. Print 2014 Jul.

[23rd Congress of the European Society for Medical Oncology, 6-10 November 1998, Athens, Greece].

Clin Ter. 1998 Nov-Dec;149(6):401-7.

Exercise and cancer: no pain, some gain?

J Clin Oncol. 2003 May 1;21(9):1651-2. doi: 10.1200/JCO.2003.12.066.

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.

Clin Cancer Res. 1998 Apr;4(4):835-46.

Gene therapy trials: a patient pathway.

Nurs Stand. 2002;17(3):39-42. doi: 10.7748/ns.17.3.39.s63.

Core symptom measures in cancer clinical trials.

作者信息

Gotay Carolyn

机构信息

Affiliation of author: University of British Columbia, Vancouver, BC (CG).

出版信息

J Natl Cancer Inst. 2014 Jul 8;106(7). doi: 10.1093/jnci/dju173. Print 2014 Jul.

DOI:10.1093/jnci/dju173

PMID:25006193

Abstract

摘要